Page last updated: 2024-11-01

omeprazole and Child Development Deviations

omeprazole has been researched along with Child Development Deviations in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
" This bioavailability study evaluates this practice in tube-fed patients with severe neurodevelopmental problems."2.76Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems. ( Boussery, K; De Cock, P; De Paepe, P; De Smet, J; Mehuys, E; Remon, JP; Van Bocxlaer, JF; Van Winckel, M; Vande Velde, S, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boussery, K1
De Smet, J1
De Cock, P1
Vande Velde, S1
Mehuys, E1
De Paepe, P1
Remon, JP1
Van Bocxlaer, JF1
Van Winckel, M1

Trials

1 trial available for omeprazole and Child Development Deviations

ArticleYear
Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems.
    British journal of clinical pharmacology, 2011, Volume: 72, Issue:6

    Topics: Adolescent; Adult; Anti-Ulcer Agents; Biological Availability; Child; Cross-Over Studies; Developmen

2011